Cloudbreak Pharma sets board meeting to review interim results, consider dividend

Cloudbreak Pharma will hold a board meeting on August 31, 2026, to review unaudited interim results for the six months ended June 30, 2026. The board will also consider recommending an interim dividend.

Cloudbreak Pharma will hold a board meeting on Aug. 31, 2026 to review unaudited interim results for the six months ended June 30, 2026. * The board will also consider an interim dividend recommendation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12291160), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)